Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kasia Lipska

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Evidence-Based Medicine|July 9, 2016
Physicians frequently fail to de-intensify treatment in older patients with diabetes and very low haemoglobin A1c or blood pressureRozalina McCoy, Kasia Lipska
JAMA|April 23, 2019
Metformin in 2019James Flory, Kasia Lipska
The Lancet. Diabetes & Endocrinology|May 9, 2016
The rising cost of diabetes care in the USAPatricia Peter, Kasia Lipska
JAMA|October 2, 2019
Metformin for Type 2 Diabetes-ReplyJames Flory, Kasia Lipska
Journal of Health Care for the Poor and Underserved|May 12, 2025
Work or Wellness? Examining the Challenges of Low-Wage Workers with Type 2 DiabetesPenelope Schlesinger, Princess Asante, Kasia Lipska, et al.
Health Affairs Scholar|May 23, 2025
Insulin rationing in states with and without insulin copay caps: a cross-sectional studyTiffany Enxia Jiang, Reshma Ramachandran, Kasia Lipska, et al.
Current Diabetes Reports|June 17, 2018
Availability and Affordability of Essential Medicines: Implications for Global Diabetes TreatmentDavid Beran, Margaret Ewen, Kasia Lipska, et al.
Journal of Diabetes and Its Complications|February 17, 2021
Glucagon use by U.S. adults with type 1 and type 2 diabetesPeter A Kahn, Shuling Liu, Rozalina McCoy, et al.
Journal of the American Heart Association|May 17, 2021
Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes MellitusArash A Nargesi, Gini P Jeyashanmugaraja, Nihar Desai, et al.
Asia-Pacific Journal of Public Health|February 19, 2013
The adherence to medications in diabetic patients in rural Kerala, IndiaUma V Sankar, Kasia Lipska, G K Mini, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Evidence-Based Medicine|July 9, 2016
Physicians frequently fail to de-intensify treatment in older patients with diabetes and very low haemoglobin A1c or blood pressureRozalina McCoy, Kasia Lipska
JAMA|April 23, 2019
Metformin in 2019James Flory, Kasia Lipska
The Lancet. Diabetes & Endocrinology|May 9, 2016
The rising cost of diabetes care in the USAPatricia Peter, Kasia Lipska
JAMA|October 2, 2019
Metformin for Type 2 Diabetes-ReplyJames Flory, Kasia Lipska
Journal of Health Care for the Poor and Underserved|May 12, 2025
Work or Wellness? Examining the Challenges of Low-Wage Workers with Type 2 DiabetesPenelope Schlesinger, Princess Asante, Kasia Lipska, et al.
Health Affairs Scholar|May 23, 2025
Insulin rationing in states with and without insulin copay caps: a cross-sectional studyTiffany Enxia Jiang, Reshma Ramachandran, Kasia Lipska, et al.
Current Diabetes Reports|June 17, 2018
Availability and Affordability of Essential Medicines: Implications for Global Diabetes TreatmentDavid Beran, Margaret Ewen, Kasia Lipska, et al.
Journal of Diabetes and Its Complications|February 17, 2021
Glucagon use by U.S. adults with type 1 and type 2 diabetesPeter A Kahn, Shuling Liu, Rozalina McCoy, et al.
Journal of the American Heart Association|May 17, 2021
Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes MellitusArash A Nargesi, Gini P Jeyashanmugaraja, Nihar Desai, et al.
Asia-Pacific Journal of Public Health|February 19, 2013
The adherence to medications in diabetic patients in rural Kerala, IndiaUma V Sankar, Kasia Lipska, G K Mini, et al.
Pageof 2